Drug shortage
Rocuronium Bromide Injection · Fresenius Kabi USA, LLC
FDA drug shortage · Current · updated Oct 6, 2026
Key facts
| Generic name | Rocuronium Bromide Injection |
|---|---|
| Company | Fresenius Kabi USA, LLC |
| Presentation | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) |
| Dosage form | Injection |
| Status | Current |
| Reason for shortage | Requirements related to complying with good manufacturing practices |
| Therapeutic category | Anesthesia |
| Package NDCs | 63323-426-10 |
| First posted | Feb 15, 2023 |
| Last updated | Oct 6, 2026 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: